Søgeresultater - Shervin Assassi

Refine Results
  1. 1
    The Role of Type 1 Interferon in Systemic Sclerosis

    The Role of Type 1 Interferon in Systemic Sclerosis af Minghua Wu, Shervin Assassi

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

    Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity? af Chandra Mohan, Shervin Assassi

    Udgivet 2015
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  3. 3
    Type I interferon dysregulation in Systemic Sclerosis

    Type I interferon dysregulation in Systemic Sclerosis af Brian Skaug, Shervin Assassi

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  4. 4
    Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need

    Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need af Ariane L. Herrick, Shervin Assassi, Christopher P. Denton

    Udgivet 2022
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  5. 5
    Genetics of scleroderma: implications for personalized medicine?

    Genetics of scleroderma: implications for personalized medicine? af Shervin Assassi, Timothy R. D. J. Radstake, Maureen D. Mayes, Javier Martı́n

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  6. 6
    Role of STAT3 in skin fibrosis and transforming growth factor beta signalling

    Role of STAT3 in skin fibrosis and transforming growth factor beta signalling af Mesias Pedroza, Sarah To, Shervin Assassi, Minghua Wu, David J. Tweardy, Sandeep K. Agarwal

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit

    Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit af Vishal Kakkar, Shervin Assassi, Yannick Allanore, Masataka Kuwana, Christopher P. Denton, Dinesh Khanna, Francesco Del Galdo

    Udgivet 2022
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  8. 8
    Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis

    Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis af John D Pauling, Gloria A. Salazar, Hui Lu, Zoë Betteridge, Shervin Assassi, Maureen D. Mayes, Neil McHugh

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Deep Learning Classification of Systemic Sclerosis Skin Using the MobileNetV2 Model

    Deep Learning Classification of Systemic Sclerosis Skin Using the MobileNetV2 Model af Metin Akay, Yong Du, Cheryl L. Sershen, Minghua Wu, Ting Y. Chen, Shervin Assassi, Chandra Mohan, Yasemin M. Akay

    Udgivet 2021
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    Does C‐Reactive Protein Predict the Long‐Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?

    Does C‐Reactive Protein Predict the Long‐Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis? af Xiaochun Liu, Maureen D. Mayes, Claudia Pedroza, Hilda T. Draeger, Emilio B. González, Brock E. Harper, John D. Reveille, Shervin Assassi

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease

    KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease af Gloria A. Salazar, Masataka Kuwana, Minghua Wu, Rosa M. Estrada‐Y‐Martin, Binwu Ying, Julio Charles, Maureen D. Mayes, Shervin Assassi

    Udgivet 2018
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  12. 12
    Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis

    Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis af Minghua Wu, Daniel J. Schneider, Maureen D. Mayes, Shervin Assassi, Frank C. Arnett, Filemon K. Tan, Michael R. Blackburn, Sandeep K. Agarwal

    Udgivet 2012
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  13. 13
    Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis

    Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis af Minghua Wu, Mesias Pedroza, Robert Lafyatis, A. J. George, Maureen D. Mayes, Shervin Assassi, Filemon K. Tan, Michael B. Brenner, Sandeep K. Agarwal

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  14. 14
    Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis

    Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis af Xiaochun Liu, Maureen D. Mayes, Filemon K. Tan, Minghua Wu, John D. Reveille, Brock E. Harper, Hilda T. Draeger, Emilio B. González, Shervin Assassi

    Udgivet 2012
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  15. 15
    Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis

    Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis af Hilda T. Draeger, Shervin Assassi, Roozbeh Sharif, Emilio B. González, Brock E. Harper, Frank C. Arnett, Ameena Manzoor, Richard A. Lange, Maureen D. Mayes

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  16. 16
    Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

    Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations af Pravitt Gourh, Frank C. Arnett, Shervin Assassi, Filemon K. Tan, Mei Huang, Laura Diekman, Maureen D. Mayes, John D. Reveille, Sandeep K. Agarwal

    Udgivet 2009
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    A one‐year, phase I/IIa, open‐label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease

    A one‐year, phase I/IIa, open‐label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease af Dinesh Khanna, Rajeev Saggar, Maureen D. Mayes, Fereidoun Abtin, Philip J. Clements, Paul Maranian, Shervin Assassi, Rajan Saggar, Ram Raj Singh, Daniel E. Furst

    Udgivet 2011
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis

    Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis af Rajpreet K. Arora-Singh, Shervin Assassi, Deborah J. del Junco, Frank C. Arnett, Marilyn Perry, Uzma Irfan, Roozbeh Sharif, Tony Mattar, Maureen D. Mayes

    Udgivet 2010
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects

    Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects af S. Hoa, Marie Hudson, Yves Troyanov, S. Proudman, Jenny Walker, Wendy Stevens, M. Nikpour, Shervin Assassi, Maureen D. Mayes, M. Wang, Murray Baron, M J Fritzler

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  20. 20
    Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis

    Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis af Tamar F Brionez, Shervin Assassi, John D. Reveille, Thomas J. Learch, Laura Diekman, Michael M. Ward, John C. Davis, Michael H. Weisman, Perry M. Nicassio

    Udgivet 2009
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: